The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF ...

The new Tempus software analyzes resting, non-ambulatory 12-lead ECG recordings to detect signs associated with having a low ...

Philips Cardiac Workstation July 17, 2025 Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution ...

Researchers at the German Center for Cardiovascular Research (DZHK) have identified a key molecule involved in a form of ...

The White House says President Trump underwent a medical exam because of swelling in his legs and has been diagnosed with a ...

NewYork-Presbyterian researchers have developed a deep learning model that increases doctors' abilities to diagnose ...

TEM stock rallies 7.3% after the FDA clears its second cardiology AI tool, witnessing a 48% surge in just three months.

Philips (NYSE: PHG) today announced the launch of its new electrocardiogram (ECG) AI marketplace for cardiac care teams.

Study findings published in the Annals of Family Medicine show high diagnostic performance of these technologies ...

Cambridge, Mass.-based Royal Philips (NYSE: PHG), a global leader in health technology, today announced the launch of the Philips ECG AI Marketplace, a platform that gives cardiac care teams access to ...

The AI model effectively spotted all subtypes of amyloidosis in the dataset, with an area under the receiver-operating characteristic curve (AUROC) of 0.93, a sensitivity of 85% for identifying ...

A 74-year-old woman develops haemolytic anaemia and stress cardiomyopathy after a tick bite, highlighting a rare cardiac complication of babesiosis.